Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
35 hedge funds and large institutions have $33.5M invested in Anthera Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
200% more call options, than puts
Call options by funds: $147K | Put options by funds: $49K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
22% more capital invested
Capital invested by funds: $27.4M → $33.5M (+$6.13M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
6% more funds holding
Funds holding: 33 → 35 (+2)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.35M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$703K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$388K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$293K |
| 5 |
PA
Perceptive Advisors
New York
|
+$149K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.26M |
| 2 |
VAM
Visium Asset Management
New York
|
-$614K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$223K |
| 4 |
JG
Jefferies Group
New York
|
-$159K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$94K |
ANTH Hedge Fund Activity: Q1 2014 in Review
35 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q1 2014, worth a combined $33.5M — up 22% from $27.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ANTH positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $4.35M. The largest seller was Sabby Management, cutting an estimated $3.26M.
- 35 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q1 2014, up from 33 in Q4 2013.
- Funds reported $33.5M of Anthera Pharmaceuticals, Inc. stock for Q1 2014, up 22% quarter-over-quarter.
- 8 funds opened new Anthera Pharmaceuticals, Inc. positions in Q1 2014 and 6 closed out, a net change of +2 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q1 2014 was Great Point Partners, an estimated $4.35M added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q1 2014 was Sabby Management, an estimated $3.26M sold.
Based on aggregated 13F filings for Q1 2014.